{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:31:00Z","timestamp":1722335460155},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005289","name":"Provincial Secretariat for Science and Technological Development","doi-asserted-by":"publisher","award":["114-451-2255\/2011-01"],"award-info":[{"award-number":["114-451-2255\/2011-01"]}],"id":[{"id":"10.13039\/501100005289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bjid.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T05:15:26Z","timestamp":1439961326000},"page":"503-509","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of brain atrophy using three drug scores in neuroasymptomatic HIV-infected patients with controlled viremia"],"prefix":"10.1016","volume":"19","author":[{"given":"Marko","family":"Novakovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Turkulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Maric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusko","family":"Kozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uros","family":"Rajkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mladen","family":"Bjelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Lucic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snezana","family":"Brkic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2015.07.002_bib0250","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1073\/pnas.0502548102","article-title":"Thinning of the cerebral cortex visualized in HIV\/AIDS reflects CD4+ T lymphocyte decline","volume":"102","author":"Thompson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bjid.2015.07.002_bib0255","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cortex.2011.03.006","article-title":"Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities","volume":"48","author":"Towgood","year":"2012","journal-title":"Cortex"},{"key":"10.1016\/j.bjid.2015.07.002_bib0260","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","article-title":"Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment","volume":"20","author":"Moore","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11682-011-9113-8","article-title":"Subcortical brain atrophy persists even in HAART-regulated HIV disease","volume":"5","author":"Becker","year":"2011","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.bjid.2015.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment","volume":"202","author":"Ed\u00e9n","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2015.07.002_bib0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAI.0b013e318249db17","article-title":"Independent effects of HIV, aging, and HAART on brain volumetric measures","volume":"59","author":"Ances","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bjid.2015.07.002_bib0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/13550280903552420","article-title":"Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era","volume":"16","author":"Cohen","year":"2010","journal-title":"J Neurovirol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0285","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00415-010-5883-y","article-title":"Structural gray and white matter changes in patients with HIV","volume":"258","author":"Kuper","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0290","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0295","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0300","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort","volume":"55","author":"D\u2019Arminio Monforte","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QAD.0b013e3283437f9a","article-title":"HIV-1 infection and cognitive impairment in the cART era: a review","volume":"25","author":"Schouten","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2015.07.002_bib0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/COH.0b013e32835fc601","article-title":"Where does HIV hide? A focus on the central nervous system","volume":"8","author":"Churchill","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0325","series-title":"XVII Conference on Retroviruses and Opportunistic Infections (San Francisco)","article-title":"Correlates of time-to-loss-of-viral-response in CSF and plasma in the CHARTER cohort","author":"Letendre","year":"2010"},{"key":"10.1016\/j.bjid.2015.07.002_bib0330","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.0b013e31820d8b0b","article-title":"Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease","volume":"76","author":"Garvey","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0335","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1468-1293.2011.00938.x","article-title":"Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?","volume":"12","author":"McManus","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.bjid.2015.07.002_bib0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3851\/IMP1374","article-title":"Antiretroviral therapy in macrophages: implication for HIV eradication","volume":"20","author":"Gavegnano","year":"2009","journal-title":"Antiviral Chem Chemother"},{"key":"10.1016\/j.bjid.2015.07.002_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.neuropsych.11050109","article-title":"Cognitive performance related to HIV-1-infected monocytes","volume":"24","author":"Kusao","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.bjid.2015.07.002_bib0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4690-7-30","article-title":"Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection","volume":"7","author":"Gras","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0355","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fvl.12.57","article-title":"Neuronal toxicity in HIV CNS disease","volume":"7","author":"Kovalevich","year":"2012","journal-title":"Future Virol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1570162X12666140526114526","article-title":"Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders","volume":"12","author":"Williams","year":"2014","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.bjid.2015.07.002_bib0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1570162X12666140526114956","article-title":"Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection","volume":"12","author":"Tavazzi","year":"2014","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.bjid.2015.07.002_bib0370","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3851\/IMP2411","article-title":"Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV","volume":"17","author":"Shikuma","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bjid.2015.07.002_bib0375","first-page":"1367","article-title":"The International HIV Dementia Scale: a new rapid screening test for HIV dementia","volume":"19","author":"Sacktor","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0380","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1590\/S0100-879X1999000900013","article-title":"Diagnosing dementia and normal aging: clinical relevance of brain ratios and cognitive performance in a Brazilian sample","volume":"32","author":"Chaves","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bjid.2015.07.002_bib0385","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1212\/WNL.42.11.2125","article-title":"Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis","volume":"42","author":"Dal Pan","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0390","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1212\/WNL.0b013e318278b5b4","article-title":"Structural brain alterations can be detected early in HIV infection","volume":"79","author":"Ragin","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0395","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.neurobiolaging.2014.01.008","article-title":"Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study","volume":"35","author":"Pfefferbaum","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bjid.2015.07.002_bib0400","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/QAD.0b013e32835b1019","article-title":"Cognitive disorders in HIV-infected patients: are they HIV-related?","volume":"27","author":"Bonnet","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0405","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ene.12006","article-title":"Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration","volume":"20","author":"Steinbrink","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0410","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13365-013-0162-1","article-title":"Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy","volume":"19","author":"Gongvatana","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0415","doi-asserted-by":"crossref","first-page":"e61738","DOI":"10.1371\/journal.pone.0061738","article-title":"HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study","volume":"8","author":"Cysique","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2015.07.002_bib0420","first-page":"543","article-title":"Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients","volume":"23","author":"Patel","year":"2002","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QAI.0b013e318274e2b0","article-title":"Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid","volume":"62","author":"Cusini","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bjid.2015.07.002_bib0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","article-title":"Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders","volume":"52","author":"Tozzi","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bjid.2015.07.002_bib0435","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1468-1293.2012.01052.x","article-title":"Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score","volume":"14","author":"Kahouadji","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.bjid.2015.07.002_bib0440","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0445","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2015.07.002_bib0450","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3851\/IMP2560","article-title":"Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia","volume":"18","author":"Ciccarelli","year":"2013","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bjid.2015.07.002_bib0455","doi-asserted-by":"crossref","first-page":"e72547","DOI":"10.1371\/journal.pone.0072547","article-title":"Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field","volume":"8","author":"Granziera","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2015.07.002_bib0460","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000000564","article-title":"Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions","volume":"83","author":"Caniglia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0465","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/1570162X12666140721122956","article-title":"HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation","volume":"12","author":"Silverstein","year":"2014","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.bjid.2015.07.002_bib0470","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13365-013-0225-3","article-title":"Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users","volume":"20","author":"Smith","year":"2014","journal-title":"J Neurovirol"},{"key":"10.1016\/j.bjid.2015.07.002_bib0475","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bjid.2015.07.002_bib0480","doi-asserted-by":"crossref","first-page":"e61949","DOI":"10.1371\/journal.pone.0061949","article-title":"Neurocognitive function in HIV infected patients on antiretroviral therapy","volume":"8","author":"Winston","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2015.07.002_bib0485","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2052-8426-2-10","article-title":"The macrophage: a therapeutic target in HIV-1 infection","volume":"2","author":"Kumar","year":"2014","journal-title":"Mol Cell Ther"},{"key":"10.1016\/j.bjid.2015.07.002_bib0490","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/135965350400900520","article-title":"The plasma and intracellular steady-state pharmacokinetics of lopinavir\/ritonavir in HIV-1-infected patients","volume":"9","author":"Crommentuyn","year":"2004","journal-title":"Antivir Ther"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867015001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867015001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T16:33:02Z","timestamp":1653064382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867015001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1413867015001348"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2015.07.002","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of brain atrophy using three drug scores in neuroasymptomatic HIV-infected patients with controlled viremia","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}